<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rmt</journal-id><journal-title-group><journal-title xml:lang="ru">Общая реаниматология</journal-title><trans-title-group xml:lang="en"><trans-title>General Reanimatology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-9779</issn><issn pub-type="epub">2411-7110</issn><publisher><publisher-name>FSBI "SRIGR" RAMS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15360/1813-9779-2007-6-208-212</article-id><article-id custom-type="elpub" pub-id-type="custom">rmt-913</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS &amp; SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>Медиаторные взаимодействия при остром респираторном дистресс-синдроме</article-title><trans-title-group xml:lang="en"><trans-title>Mediator Interactions in Acute Respiratory Distress Syndrome</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлов</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlov</surname><given-names>K. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дубова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dubova</surname><given-names>Ye. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мишнёв</surname><given-names>О. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Mishnyov</surname><given-names>O. D.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щёголев</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shchegolev</surname><given-names>A. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ Институт хирургии имени А. В. Вишневского Росмедтехнологий, Москва</institution></aff><aff xml:lang="en"><institution>A. V. Vishnevsky Institute of Surgery, Russian Agency for Medical Technologies, Moscow</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>20</day><month>12</month><year>2007</year></pub-date><volume>3</volume><issue>6</issue><issue-title>Том III № 5-6 2007 г.</issue-title><fpage>208</fpage><lpage>212</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Павлов К.А., Дубова Е.А., Мишнёв О.Д., Щёголев А.И., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Павлов К.А., Дубова Е.А., Мишнёв О.Д., Щёголев А.И.</copyright-holder><copyright-holder xml:lang="en">Pavlov K.A., Dubova Y.A., Mishnyov O.D., Shchegolev A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.reanimatology.com/rmt/article/view/913">https://www.reanimatology.com/rmt/article/view/913</self-uri><abstract><p>В обзоре литературы освещены вопросы взаимодействия многочисленных медиаторов, являющихся инициаторами и основными движущими стимулами возникновения и развития острого респираторного дистресс-синдрома. Основные семейства медиаторов включают цитокины, медиаторы липидного происхождения, компоненты внеклеточного матрик-са, медиаторы оксидантной и антиоксидантной систем, протеиназы и компоненты системы свертывания. Представители каждого из указанных семейств играют важную роль на каждом из этапов развития ОРДС: повышение проницаемости легочных капилляров, хемотаксис нейтрофильных гранулоцитов, макрофагов и лимфоцитов, вторичное повреждение эндотелиоцитов, легочного эпителия и сурфактанта, возникновение легочной гипертензии, а также развитие легочного фиброза в завершающей стадии ОРДС. Интенсивность клинических проявлений зависит от взаимодействия между про- и противовоспалительными медиаторами, начинающегося на самых ранних этапах их развития. Отмечена важная роль поиска специфических антагонистов провоспалительных медиаторов и их рецепторов для дальнейшего использования в клинической практике и, прежде всего, для разработки новых, более эффективных методов лечения ОРДС.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>The review of literature covers the interaction of numerous mediators that are initiators and major motive forces of the occurrence and development of acute respiratory distress syndrome (ARDS). The major mediator families include cytokines, mediators of lipid origin, components of the extracellular matrix, mediators of the oxidative and antioxidative systems, proteinases, and components of the coagulation system. The representatives of each of the above families play an important role at each developmental stage of ARDS: an increase in the permeability of pulmonary capillaries, chemotaxis of neutrophilic granulocytes, macrophages, and lymphocytes, secondary damage to endotheliocytes, pulmonary epithelium and surfactant, occurrence of pulmonary hypertension, and development of pulmonary fibrosis in late-stage ARDS. The intensity of clinical manifestations depends on the interaction between pro- and anti-inflammatory mediators, which starts at the earliest stages of their development. Searches for specific antagonists of proinflammatory mediators and their receptors were noted to be of importance for further clinical application and, first all, development of more effective treatments for ARDS.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>острое повреждение легких</kwd><kwd>острый респираторный дистресс-синдром</kwd><kwd>медиаторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>acute lung injury</kwd><kwd>acute respiratory distress syndrome</kwd><kwd>mediators</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Мишнёв О. Д., Щёголев А. И. Патологическая анатомия ОРДС. В кн.: Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дистресс-синдром. М.: Литтерра; 2007. 48—67.</mixed-citation><mixed-citation xml:lang="en">Мишнёв О. Д., Щёголев А. И. Патологическая анатомия ОРДС. В кн.: Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дистресс-синдром. М.: Литтерра; 2007. 48—67.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Руднов В. А., Левит А. Л., Бутров А. В., Звягин А. А. Эпидемиология и факторы риска. Там же. 26—28.</mixed-citation><mixed-citation xml:lang="en">Руднов В. А., Левит А. Л., Бутров А. В., Звягин А. А. Эпидемиология и факторы риска. Там же. 26—28.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ricou B. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): Mediator network. Intensivmed. 1998; 35: 10—21.</mixed-citation><mixed-citation xml:lang="en">Ricou B. Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): Mediator network. Intensivmed. 1998; 35: 10—21.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Игнатенко О. В., Проценко Д. Н., Ярошецкий А. И., Гельфанд Б. Р. Вентилятор-ассоциированное повреждение легких. Там же. 114—126.</mixed-citation><mixed-citation xml:lang="en">Игнатенко О. В., Проценко Д. Н., Ярошецкий А. И., Гельфанд Б. Р. Вентилятор-ассоциированное повреждение легких. Там же. 114—126.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Marks J. D., Berman-Marks C., Luce J. M. et al. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effect of methylprednisolone administration. Amer. Rev. Respir. Dis. 1990; 141: 94—97.</mixed-citation><mixed-citation xml:lang="en">Marks J. D., Berman-Marks C., Luce J. M. et al. Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effect of methylprednisolone administration. Amer. Rev. Respir. Dis. 1990; 141: 94—97.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pierce J. D., Pierce J., Stremming S., Fakhari M. The role of apoptosis in respiratory diseases. Clin. Nurse. Spec. 2007; 21 (1): 22—30.</mixed-citation><mixed-citation xml:lang="en">Pierce J. D., Pierce J., Stremming S., Fakhari M. The role of apoptosis in respiratory diseases. Clin. Nurse. Spec. 2007; 21 (1): 22—30.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhopadhyay S., Hoidal J. R., Mukherjee T. K. Role of TNF-alpha in pulmonary pathophysiology. Respir. Res. 2006; 7: 125.</mixed-citation><mixed-citation xml:lang="en">Mukhopadhyay S., Hoidal J. R., Mukherjee T. K. Role of TNF-alpha in pulmonary pathophysiology. Respir. Res. 2006; 7: 125.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Pugin J., Ricou B., Steinberg K. P. et al. Proinflammatory activity in bronchoalveolar lavagefluid from ARDS patients: a prominent role for interleukin-1. Amer. J. Respir. Crit. Care. Med. 1996; 153: 1850—1856.</mixed-citation><mixed-citation xml:lang="en">Pugin J., Ricou B., Steinberg K. P. et al. Proinflammatory activity in bronchoalveolar lavagefluid from ARDS patients: a prominent role for interleukin-1. Amer. J. Respir. Crit. Care. Med. 1996; 153: 1850—1856.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmerman J. J. Understanding another acute respiratory distress syndrome. Crit. Care Med. 2007; 35 (3): 974—975.</mixed-citation><mixed-citation xml:lang="en">Zimmerman J. J. Understanding another acute respiratory distress syndrome. Crit. Care Med. 2007; 35 (3): 974—975.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Donnelly S. C., Strieter R. M., Kunkel S. L. et al. Interleukin-8 and development of adult distress syndrome in at risk patient groups. Lancet 1993; 41: 643—647.</mixed-citation><mixed-citation xml:lang="en">Donnelly S. C., Strieter R. M., Kunkel S. L. et al. Interleukin-8 and development of adult distress syndrome in at risk patient groups. Lancet 1993; 41: 643—647.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Terminella L., Sharma G. Diagnostic studies in patients with acute respiratory distress syndrome. Semin. Thorac. Cardiovasc. Surg. 2006; 18 (1): 2—7.</mixed-citation><mixed-citation xml:lang="en">Terminella L., Sharma G. Diagnostic studies in patients with acute respiratory distress syndrome. Semin. Thorac. Cardiovasc. Surg. 2006; 18 (1): 2—7.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mulligan M. S., Jones M. L., Vaporciyan A. A. et al. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 1993; 151: 5666—5674.</mixed-citation><mixed-citation xml:lang="en">Mulligan M. S., Jones M. L., Vaporciyan A. A. et al. Protective effects of IL-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 1993; 151: 5666—5674.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Donnelly S. C., Strieter R. M., Reid P. T. et al. The association betweenmortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 1996; 125: 191—196.</mixed-citation><mixed-citation xml:lang="en">Donnelly S. C., Strieter R. M., Reid P. T. et al. The association betweenmortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 1996; 125: 191—196.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Frank J. A., Parsons P. E., Matthay M. A. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006; 130 (6): 1906—1914.</mixed-citation><mixed-citation xml:lang="en">Frank J. A., Parsons P. E., Matthay M. A. Pathogenetic significance of biological markers of ventilator-associated lung injury in experimental and clinical studies. Chest 2006; 130 (6): 1906—1914.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ulich T. R., Yin S., Guo K. et al. Intratracheal injection of endotoxin and cytokines II. Interleukin-6 and transforming growth factor-binhibit acute inflammation. Amer. J. Pathol. (USA) 1991; 138: 1097—1101.</mixed-citation><mixed-citation xml:lang="en">Ulich T. R., Yin S., Guo K. et al. Intratracheal injection of endotoxin and cytokines II. Interleukin-6 and transforming growth factor-binhibit acute inflammation. Amer. J. Pathol. (USA) 1991; 138: 1097—1101.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shenkar R., Coulson W. F., Abraham E. Anti-transforming growth factorb monoclonal antibodies prevent lung injury in hemorrhaged mice. Amer. J. Respir. Cell. Mol. Biol. 1994; 11: 351—357.</mixed-citation><mixed-citation xml:lang="en">Shenkar R., Coulson W. F., Abraham E. Anti-transforming growth factorb monoclonal antibodies prevent lung injury in hemorrhaged mice. Amer. J. Respir. Cell. Mol. Biol. 1994; 11: 351—357.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Пальцев М. А. (ред.) Введение в молекулярную медицину. М.: Медицина; 2004.</mixed-citation><mixed-citation xml:lang="en">Пальцев М. А. (ред.) Введение в молекулярную медицину. М.: Медицина; 2004.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990; 265: 621—636.</mixed-citation><mixed-citation xml:lang="en">Heinrich P. C., Castell J. V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990; 265: 621—636.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Пальцев М. А., Иванов А. А., Северин С. Е. Межклеточные взаимодействия. М.: Медицина; 2003.</mixed-citation><mixed-citation xml:lang="en">Пальцев М. А., Иванов А. А., Северин С. Е. Межклеточные взаимодействия. М.: Медицина; 2003.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Miyake Y., Kaise H., Isono K., Koseki H. Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II. Cells. J. Immunol. 2007; 178 (8): 5001—5009.</mixed-citation><mixed-citation xml:lang="en">Miyake Y., Kaise H., Isono K., Koseki H. Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II. Cells. J. Immunol. 2007; 178 (8): 5001—5009.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Heffner J. E., Repine J. E. Pulmonary strategies of antioxidant defense. Amer. Rev. Respir. Dis. 1989; 140: 531—554.</mixed-citation><mixed-citation xml:lang="en">Heffner J. E., Repine J. E. Pulmonary strategies of antioxidant defense. Amer. Rev. Respir. Dis. 1989; 140: 531—554.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ware L. B. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir. Crit. Care Med. 2006; 27 (4): 337—349.</mixed-citation><mixed-citation xml:lang="en">Ware L. B. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir. Crit. Care Med. 2006; 27 (4): 337—349.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ishii Y., Partridge C. A., Del Vecchio P. J., Malik A. B. Tumor necrosis factor — a mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2 . J. Clin. Invest. 1992; 89: 794—802.</mixed-citation><mixed-citation xml:lang="en">Ishii Y., Partridge C. A., Del Vecchio P. J., Malik A. B. Tumor necrosis factor — a mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2 . J. Clin. Invest. 1992; 89: 794—802.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Warner B. B., Burhans M. S., Clark J. C., Wisp J. R. Tumor necrosis factor — a increases Mn-SOD expression: protection against oxidant injury. Amer. J. Physiol. 1991; 260: L296—L301.</mixed-citation><mixed-citation xml:lang="en">Warner B. B., Burhans M. S., Clark J. C., Wisp J. R. Tumor necrosis factor — a increases Mn-SOD expression: protection against oxidant injury. Amer. J. Physiol. 1991; 260: L296—L301.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Motterlini R., Foresti R., Intaglietta M., Winslow R. M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Amer. J. Physiol. 1996; 270: H107—H114.</mixed-citation><mixed-citation xml:lang="en">Motterlini R., Foresti R., Intaglietta M., Winslow R. M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Amer. J. Physiol. 1996; 270: H107—H114.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kubes P., Granger D. N. Nitric oxide modulates microvascular permeability. Amer. J. Physiol. 1992; 262: H611—H615.</mixed-citation><mixed-citation xml:lang="en">Kubes P., Granger D. N. Nitric oxide modulates microvascular permeability. Amer. J. Physiol. 1992; 262: H611—H615.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Hill M. E., Bird I. N., Daniels R. H. et al. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but no transmigration across IL-1 b-treated endothelial monolyers. J. Immunol. (USA) 1994; 153: 3673—3683.</mixed-citation><mixed-citation xml:lang="en">Hill M. E., Bird I. N., Daniels R. H. et al. Endothelial cell-associated platelet-activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but no transmigration across IL-1 b-treated endothelial monolyers. J. Immunol. (USA) 1994; 153: 3673—3683.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Y., Xu J., Zhou C., Wu Z. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 2005; 171: 850—857.</mixed-citation><mixed-citation xml:lang="en">Jiang Y., Xu J., Zhou C., Wu Z. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 2005; 171: 850—857.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Henson P. M., Barnes P. J., Banks-Schlegel S. P. Platelet-activation factor: role in pulmonary injury and dysfunction and blood abnormalities (NHLB Workshop summary). Amer. Rev. Respir. Dis. 1992; 145: 726—731.</mixed-citation><mixed-citation xml:lang="en">Henson P. M., Barnes P. J., Banks-Schlegel S. P. Platelet-activation factor: role in pulmonary injury and dysfunction and blood abnormalities (NHLB Workshop summary). Amer. Rev. Respir. Dis. 1992; 145: 726—731.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Rabinovici R., Bugelski P. J., Esser K. M. et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J. Appl. Physiol. 1993; 74: 1791—1802.</mixed-citation><mixed-citation xml:lang="en">Rabinovici R., Bugelski P. J., Esser K. M. et al. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J. Appl. Physiol. 1993; 74: 1791—1802.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Matsumoto K., Taki F., Kondoh Y. et al. Plateletactivating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin. Exp. Pharmacol. Physiol. 1992; 19: 509—515.</mixed-citation><mixed-citation xml:lang="en">Matsumoto K., Taki F., Kondoh Y. et al. Plateletactivating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Clin. Exp. Pharmacol. Physiol. 1992; 19: 509—515.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Belperio J. A., Keane M. P., Lynch J. P., Strieter R. M. The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin. Respir. Crit. Care Med. 2006; 27 (4): 350—364.</mixed-citation><mixed-citation xml:lang="en">Belperio J. A., Keane M. P., Lynch J. P., Strieter R. M. The role of cytokines during the pathogenesis of ventilator-associated and ventilator-induced lung injury. Semin. Respir. Crit. Care Med. 2006; 27 (4): 350—364.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Smith C. S., Parker L., Shearer W. T. Cytokine regulation by plateletactivating factor in a human B cell line. J. Immunol. (USA) 1994; 153: 3997—4005.</mixed-citation><mixed-citation xml:lang="en">Smith C. S., Parker L., Shearer W. T. Cytokine regulation by plateletactivating factor in a human B cell line. J. Immunol. (USA) 1994; 153: 3997—4005.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Moya F. R., Hoffman D. R., Zhao B., Johnston J. M. Platelet-activating factor in surfactant preparations. Lancet 1993; 341: 858—860.</mixed-citation><mixed-citation xml:lang="en">Moya F. R., Hoffman D. R., Zhao B., Johnston J. M. Platelet-activating factor in surfactant preparations. Lancet 1993; 341: 858—860.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Puneet P., Moochhala S., Bhatia M. Chemokines in acute respiratory distress syndrome Amer. J. Physiol. Lung Cell Mol. Physiol. 2005; 288: L3—L15.</mixed-citation><mixed-citation xml:lang="en">Puneet P., Moochhala S., Bhatia M. Chemokines in acute respiratory distress syndrome Amer. J. Physiol. Lung Cell Mol. Physiol. 2005; 288: L3—L15.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell E. J., Senior R. M., Welgus H. G. Extracellular matrix injury during lung inflammation. Chest 1987; 92: 161—167.</mixed-citation><mixed-citation xml:lang="en">Campbell E. J., Senior R. M., Welgus H. G. Extracellular matrix injury during lung inflammation. Chest 1987; 92: 161—167.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Киров М. Ю., Недашковский Э. В., Кассиль В. Л., Багдатьев В. Е. Этиология и патогенез. В кн.: Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дистресс-синдром. М.: Литтерра; 2007. 29—39.</mixed-citation><mixed-citation xml:lang="en">Киров М. Ю., Недашковский Э. В., Кассиль В. Л., Багдатьев В. Е. Этиология и патогенез. В кн.: Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дистресс-синдром. М.: Литтерра; 2007. 29—39.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Woessner J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB. J. 1991; 5: 2145—2154.</mixed-citation><mixed-citation xml:lang="en">Woessner J. F. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB. J. 1991; 5: 2145—2154.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Elkington P. T. G., Friedland J. S. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006; 61: 259—266.</mixed-citation><mixed-citation xml:lang="en">Elkington P. T. G., Friedland J. S. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006; 61: 259—266.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Torii K., Iida K. I., Miyazaki Y. et al. High concentrations of matrix metalloproteinases in bronchoalveolar lavaga fluid of patients with adult respiratory distress syndrome. Amer. J. Respir. Crit. Care Med. 1997; 155: 43—46.</mixed-citation><mixed-citation xml:lang="en">Torii K., Iida K. I., Miyazaki Y. et al. High concentrations of matrix metalloproteinases in bronchoalveolar lavaga fluid of patients with adult respiratory distress syndrome. Amer. J. Respir. Crit. Care Med. 1997; 155: 43—46.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Perez R. L., Roman J. Fibrin enhances the expression of IL-1 by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J. Immunol. 1995; 154: 1879—1887.</mixed-citation><mixed-citation xml:lang="en">Perez R. L., Roman J. Fibrin enhances the expression of IL-1 by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J. Immunol. 1995; 154: 1879—1887.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Lotz M., Guerne P. A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 1991; 266: 2017—2020.</mixed-citation><mixed-citation xml:lang="en">Lotz M., Guerne P. A. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 1991; 266: 2017—2020.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lacraz S., Nicol L., Galve-de Rochemonteix B. et al. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 1992; 90: 383—388.</mixed-citation><mixed-citation xml:lang="en">Lacraz S., Nicol L., Galve-de Rochemonteix B. et al. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 1992; 90: 383—388.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Jawa R. S. What is new in cytokine research related to trauma. Critical Care. J. Intens. Care Med. 2006; 21 (2): 63—85.</mixed-citation><mixed-citation xml:lang="en">Jawa R. S. What is new in cytokine research related to trauma. Critical Care. J. Intens. Care Med. 2006; 21 (2): 63—85.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Ventrice E. A., Marti-Sistac O., Gonzalvo R., Villagra A. Molecular and biophysical mechanisms and modulation of ventilator-induced lung injury. Med. Intensiva 2007; 31 (2): 73—82.</mixed-citation><mixed-citation xml:lang="en">Ventrice E. A., Marti-Sistac O., Gonzalvo R., Villagra A. Molecular and biophysical mechanisms and modulation of ventilator-induced lung injury. Med. Intensiva 2007; 31 (2): 73—82.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Fuchs-Buder T., De Moerloose Ph., Ricou B. et al. Time course of procoagulant activity and d-dimer in bronchoalveolar fluid of patients at risk for or with ARDS. Amer. J. Respir. Crit. Care Med. 1996; 153: 164—167.</mixed-citation><mixed-citation xml:lang="en">Fuchs-Buder T., De Moerloose Ph., Ricou B. et al. Time course of procoagulant activity and d-dimer in bronchoalveolar fluid of patients at risk for or with ARDS. Amer. J. Respir. Crit. Care Med. 1996; 153: 164—167.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Medford A. R. L., Millar A. B. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 2006; 61: 621—626.</mixed-citation><mixed-citation xml:lang="en">Medford A. R. L., Millar A. B. Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 2006; 61: 621—626.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Murphy G., Atkinson S., Ward R. et al. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. In Ann.: N.Y. Acad. Sci. 1992; 667. 1—12.</mixed-citation><mixed-citation xml:lang="en">Murphy G., Atkinson S., Ward R. et al. The role of plasminogen activators in the regulation of connective tissue metalloproteinases. In Ann.: N.Y. Acad. Sci. 1992; 667. 1—12.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Pison U., May M., Neuendank A. et al. Host defense capacities of pulmonary surfactant: Evidence for non-surfactant functions of the surfactant system. Eur. J. Clin. Invest. 1994; 24: 586—599.</mixed-citation><mixed-citation xml:lang="en">Pison U., May M., Neuendank A. et al. Host defense capacities of pulmonary surfactant: Evidence for non-surfactant functions of the surfactant system. Eur. J. Clin. Invest. 1994; 24: 586—599.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Baudouin S. V. Surfactant medication for acute respiratory distress syndrome. Thorax 1997; 52: S9—15.</mixed-citation><mixed-citation xml:lang="en">Baudouin S. V. Surfactant medication for acute respiratory distress syndrome. Thorax 1997; 52: S9—15.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Rooney S. A., Young S. L., Mendelson C. R. Molecular and cellular processing of lung surfactant. FASEB J. 1994; 8: 957—967.</mixed-citation><mixed-citation xml:lang="en">Rooney S. A., Young S. L., Mendelson C. R. Molecular and cellular processing of lung surfactant. FASEB J. 1994; 8: 957—967.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Greene K. E., Gardai S., Henson P. M. SP-A and SP-D inhibit spontaneous neutrophil apoptosis via activation of the PI-3 kinase/AKT. Amer. J. Respir. Crit. Care Med. 2001; 163: 23.</mixed-citation><mixed-citation xml:lang="en">Greene K. E., Gardai S., Henson P. M. SP-A and SP-D inhibit spontaneous neutrophil apoptosis via activation of the PI-3 kinase/AKT. Amer. J. Respir. Crit. Care Med. 2001; 163: 23.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Bellingan G. J. The pathogenesis of ALI/ARDS. Thorax 2002; 57: 540—546.</mixed-citation><mixed-citation xml:lang="en">Bellingan G. J. The pathogenesis of ALI/ARDS. Thorax 2002; 57: 540—546.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Venkitaraman A. R., Hall S. B., Whitsett J. A., Notter R. H. Enhancement of biophysical activity of lung surfactant extracts and phospholipidapoprotein mixtures by surfactant protein. Chem. Phys. Lipids. 1990; 56: 185—194.</mixed-citation><mixed-citation xml:lang="en">Venkitaraman A. R., Hall S. B., Whitsett J. A., Notter R. H. Enhancement of biophysical activity of lung surfactant extracts and phospholipidapoprotein mixtures by surfactant protein. Chem. Phys. Lipids. 1990; 56: 185—194.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Horowitz S., Watkins R. H., Auten R. L. et al. Differential accumulation of surfactant protein A, B, and C mRNAs in two epithelial cell types of hyperoxic lung. Amer. J. Respir. Cell Mol. Biol. 1991; 5: 511—515.</mixed-citation><mixed-citation xml:lang="en">Horowitz S., Watkins R. H., Auten R. L. et al. Differential accumulation of surfactant protein A, B, and C mRNAs in two epithelial cell types of hyperoxic lung. Amer. J. Respir. Cell Mol. Biol. 1991; 5: 511—515.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Baker C. S., Evans T. W., Randle B. J. et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999; 353: 1232—1237.</mixed-citation><mixed-citation xml:lang="en">Baker C. S., Evans T. W., Randle B. J. et al. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999; 353: 1232—1237.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Balibrea-Cantero J. L., Arias-Diaz L., Garcia C. et al. Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-a in human type II pneumocytes. Amer. J. Respir. Crit. Care 1994; 149: 699—706.</mixed-citation><mixed-citation xml:lang="en">Balibrea-Cantero J. L., Arias-Diaz L., Garcia C. et al. Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-a in human type II pneumocytes. Amer. J. Respir. Crit. Care 1994; 149: 699—706.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дистресс-синдром. М.: Литтерра; 2007. 232.</mixed-citation><mixed-citation xml:lang="en">Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дистресс-синдром. М.: Литтерра; 2007. 232.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Гельфанд Б. Р., Игнатенко О. В., Недашковский Э. В., Киров М. Ю. Инфузионная терапия. Там же. 190—200.</mixed-citation><mixed-citation xml:lang="en">Гельфанд Б. Р., Игнатенко О. В., Недашковский Э. В., Киров М. Ю. Инфузионная терапия. Там же. 190—200.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
